Becky Williams-Hall


Becky has extensive experience conducting research relating to the development, selection, and validation of clinical outcome assessments (COA) and oversees project teams in the delivery of literature and COA reviews, content validity studies comprising concept elicitation and cognitive debriefing methodology, psychometric evaluation, trial experience studies, and the preparation of dossiers/briefing books for regulatory submission. Becky has experience in a variety of disease areas including rare disease, pulmonology, dermatology, otorhinolaryngology, gastroenterology, and rheumatology and has published this research in peer-review journals and at clinical-, health outcomes-, and quality of life-centered conferences.

Becky has experience of working on large multi-sponsor consortium and FDA-funded projects. Most notably, Becky was involved in the development of the Asthma Daytime and Nighttime Symptom Diaries (ADSD and ANSD), two PRO measures qualified by FDA’s COA qualification program for the evaluation of symptom severity in adolescents and adults with asthma and she is currently working on a related multi-year follow-up study seeking qualification of two measures for use in pediatric asthma. As part of her role at Adelphi Values, Becky leads initiatives relating to the management of project finances and team recruitment.

Prior to joining Adelphi Values Becky worked for the Medical Research Council’s Institute of Hearing Research and gained an MMedSci in Clinical Communication Science (Speech and Language Therapy) from The University of Sheffield and BSc in Psychology from The University of Birmingham.

Outside of work, Becky enjoys holidaying and exploring new places with her husband and son, exercising, and ‘attempting’ the latest home DIY and renovation projects seen on Pinterest.